Skip to main content
Uncategorized

Eduard Batlle awarded the Dr. Josef Steiner Cancer Research Award

By 11 de October de 2013November 18th, 2020No Comments
< Back to news
Eduard Batlle leads the Colorectal Cancer Laboratory (Photo: IRB).
 11.10.2013

Eduard Batlle awarded the Dr. Josef Steiner Cancer Research Award

Eduard Batlle, ICREA Professor, Oncology Programme Coordinator and principal investigator of the Colorectal Cancer Laboratory at the Institute for Research in Biomedicine (IRB) and Joan Seoane, ICREA Professor, Director of Translational Research at the Vall d'Hebron Institute of Oncology (VHIO) and Principal Investigator of the Gene Expression and Cancer Group, have won the Dr. Josef Steiner Cancer Research Award 2013 for their dedicated work in oncology.


Consisting of a €400,000 grant each to fuel a research project over a four-year period, as well as a personal prize for each researcher in recognition of their outstanding professional development to-date, both researchers will receive the shared award at a special ceremony taking place today at the University of Bern (Switzerland).

Dr. Batlle´s laboratory pioneered the identification of a population of malignant cells capable of spreading the cancer to the liver and lungs, the organs in which metastasis most frequently occurs in patients with colon cancer.

This research opens avenues for the development of new therapeutic strategies to block metastasis. In addition, Batlle, in collaboration with the Botín Foundation, is currently translating his research findings to the clinic through a project called Colostage, a test that will identify colon cancer patients that are at high risk of developing metastasis further to treatment.

The Dr. Josef Steiner Foundation supports research into the mechanisms that trigger cancer and the development of more effective diagnostic tools and treatments to fight this disease. The aims of the Foundation include honouring studies and researchers that develop new concepts and diagnostic or therapeutic approaches, and raise public awareness on and around the importance of preclinical research as the first essential element upon which to build translational studies.